$BYLT
Elite Performance Holding Corp

2021 Q1 Form 10-Q Financial Statement

#000147793223006651 Filed on September 06, 2023

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $1.599K $15.28K
YoY Change -89.54%
Cost Of Revenue $5.848K $92.02K
YoY Change -93.65%
Gross Profit -$4.249K -$76.74K
YoY Change -94.46%
Gross Profit Margin -265.73% -502.13%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $370.2K $289.8K
YoY Change 27.76%
Operating Profit -$374.5K -$366.5K
YoY Change 2.17%
Interest Expense $23.31K $29.18K
YoY Change -20.12%
% of Operating Profit
Other Income/Expense, Net -$23.31K -$29.18K
YoY Change -20.12%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$397.8K -$395.7K
YoY Change 0.52%
Net Earnings / Revenue -24876.49% -2589.16%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $8.789K $252.00 $78.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $10.13K $10.13K
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $18.92K $10.38K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $49.49K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $18.92K $10.38K
Total Long-Term Assets $0.00 $0.00
Total Assets $18.92K $10.38K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $619.0K $609.5K
YoY Change
Accrued Expenses $111.5K $107.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.483M $1.437M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $201.4K $201.4K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.483M $1.437M
Total Long-Term Liabilities $201.4K $201.4K
Total Liabilities $1.684M $1.639M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$4.119M -$3.721M
YoY Change
Common Stock $9.195K $8.472K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.665M -$1.628M -$1.235M
YoY Change
Total Liabilities & Shareholders Equity $18.92K $10.38K
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income -$397.8K -$395.7K
YoY Change 0.52%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$200.3K -$231.7K
YoY Change -13.56%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $208.8K $64.00K
YoY Change 226.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $208.8K $214.9K
YoY Change -2.83%
NET CHANGE
Cash From Operating Activities -$200.3K -$231.7K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $208.8K $214.9K
Net Change In Cash $8.537K -$16.81K
YoY Change -150.8%
FREE CASH FLOW
Cash From Operating Activities -$200.3K -$231.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8789 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
252 usd
CY2020Q4 us-gaap Inventory Net
InventoryNet
10128 usd
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
201352 usd
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
201352 usd
CY2021Q1 us-gaap Liabilities
Liabilities
1683940 usd
CY2020Q4 us-gaap Liabilities
Liabilities
1638528 usd
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
9195 usd
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8472 usd
CY2021Q1 elite Shares To Be Issued
SharesToBeIssued
13803 usd
CY2020Q4 elite Shares To Be Issued
SharesToBeIssued
13803 usd
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2429759 usd
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2069582 usd
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4118780 usd
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3721005 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1665023 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1628148 usd
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18917 usd
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2019 elite Debt Original Debt Discount Amount
DebtOriginalDebtDiscountAmount
45500 usd
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
000-55987
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Elite Performance Holding Corp.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5034226
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3301 NE 1st Ave Suite M704
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
CY2021Q1 dei City Area Code
CityAreaCode
844
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001753681
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84738300 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91956300 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
426-2958
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 us-gaap Assets
Assets
18917 usd
CY2020Q4 us-gaap Assets
Assets
10380 usd
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
130001300 shares
CY2021Q1 us-gaap Assets Current
AssetsCurrent
18917 usd
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
619035 usd
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
609505 usd
CY2021Q1 elite Accounts Payable And Accrued Expenses Related Party
AccountsPayableAndAccruedExpensesRelatedParty
253071 usd
CY2020Q4 elite Accounts Payable And Accrued Expenses Related Party
AccountsPayableAndAccruedExpensesRelatedParty
222738 usd
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
111482 usd
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
106982 usd
CY2021Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
499000 usd
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
497951 usd
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1482588 usd
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1437176 usd
CY2021Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
201352 usd
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
201352 usd
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91956300 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84738300 shares
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10380 usd
CY2021Q1 us-gaap Revenues
Revenues
1599 usd
CY2020Q1 us-gaap Revenues
Revenues
15283 usd
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5848 usd
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
92023 usd
CY2021Q1 us-gaap Gross Profit
GrossProfit
-4249 usd
CY2020Q1 us-gaap Gross Profit
GrossProfit
-76740 usd
CY2021Q1 us-gaap Legal Fees
LegalFees
101903 usd
CY2020Q1 us-gaap Legal Fees
LegalFees
12627 usd
CY2021Q1 us-gaap Advertising Expense
AdvertisingExpense
178206 usd
CY2020Q1 us-gaap Advertising Expense
AdvertisingExpense
121896 usd
CY2021Q1 elite Consulting Expense
ConsultingExpense
51830 usd
CY2020Q1 elite Consulting Expense
ConsultingExpense
93806 usd
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38277 usd
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61452 usd
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
370216 usd
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
289781 usd
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-374465 usd
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-366521 usd
CY2021Q1 us-gaap Interest Expense
InterestExpense
23310 usd
CY2020Q1 us-gaap Interest Expense
InterestExpense
29180 usd
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23310 usd
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29180 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-397775 usd
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-395701 usd
CY2021Q1 elite Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2020Q1 elite Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2021Q1 elite Basic And Diluted Weighted Average Number Of Share Outstanding
BasicAndDilutedWeightedAverageNumberOfShareOutstanding
90038767 shares
CY2020Q1 elite Basic And Diluted Weighted Average Number Of Share Outstanding
BasicAndDilutedWeightedAverageNumberOfShareOutstanding
65180344 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-928567 usd
CY2020Q1 us-gaap Proceeds From Commissions Received
ProceedsFromCommissionsReceived
64000 usd
CY2020Q1 elite Shares Issued For Finance Fees Amount
SharesIssuedForFinanceFeesAmount
20000 usd
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000 usd
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-395701 usd
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-1235268 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1628148 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
152100 usd
CY2021Q1 elite Shares Issued For Subscriptions Amount
SharesIssuedForSubscriptionsAmount
208800 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-397775 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1665023 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-397775 usd
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-395701 usd
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1049 usd
CY2021Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15171 usd
CY2021Q1 elite Shares Issued For Services
SharesIssuedForServices
152100 usd
CY2020Q1 elite Shares Issued For Services
SharesIssuedForServices
5000 usd
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-192 usd
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-48205 usd
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2638 usd
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
30333 usd
CY2020Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
46276 usd
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14030 usd
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
143326 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-200263 usd
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-231687 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
CY2020Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
881 usd
CY2021Q1 elite Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
0 usd
CY2020Q1 elite Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
0 usd
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
208800 usd
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
64000 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
208800 usd
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
214881 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8537 usd
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16806 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16884 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8789 usd
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78 usd
CY2021Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2020Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021Q1 elite Shares Issued For Commitment Fees
SharesIssuedForCommitmentFees
0 usd
CY2020Q1 elite Shares Issued For Commitment Fees
SharesIssuedForCommitmentFees
20000 usd
CY2021Q1 elite Shares Issued For Financing Fees
SharesIssuedForFinancingFees
0 usd
CY2020Q1 elite Shares Issued For Financing Fees
SharesIssuedForFinancingFees
0 usd
CY2021Q1 elite Shares Issued For Note Payable Conversion
SharesIssuedForNotePayableConversion
0 usd
CY2020Q1 elite Shares Issued For Note Payable Conversion
SharesIssuedForNotePayableConversion
0 usd
CY2018Q1 us-gaap Shares Issued
SharesIssued
100000000 shares
CY2021Q1 elite Retained Earnings Accumulated Deficits
RetainedEarningsAccumulatedDeficits
-4118780 usd
CY2021Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a calendar year-end. </p>
CY2021Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2021Q1 us-gaap Inventory Net
InventoryNet
10128 usd
CY2020Q4 us-gaap Inventory Net
InventoryNet
10128 usd
CY2021Q1 us-gaap Convertible Debt
ConvertibleDebt
499000 usd
CY2021Q1 elite Common Stock Convertible Shares Issuable
CommonStockConvertibleSharesIssuable
6830000 shares
CY2021Q1 elite Share Issued
ShareIssued
276060 shares
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q1 us-gaap Revenues
Revenues
1599 usd
CY2020Q1 us-gaap Revenues
Revenues
15283 usd
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.35 pure
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4188780 usd
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
864944 usd
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
864944 usd
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
864944 usd
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
781411 usd
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
864944 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
781411 usd
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2020Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
439545 usd
CY2020Q3 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.06 pure
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 elite Description Of Shares Registered In The S1 Registration Statement
DescriptionOfSharesRegisteredInTheS1RegistrationStatement
the company has raised $1,250,000 (25,000,000 shares issued and 0 of shares to be issued) through a registered offering for $1,250,000 which was registered with the SEC through an S1 registration statement which went effective on April 23, 2019
CY2020 elite Stock Issued During Period Sharesfinancing Fees
StockIssuedDuringPeriodSharesfinancingFees
400000 shares
CY2020 elite Stock Issued During Period Value Financing Fees
StockIssuedDuringPeriodValueFinancingFees
20000 usd
CY2020Q3 elite Impairment License Fees
ImpairmentLicenseFees
10000 usd
CY2020Q3 elite Net Impair License
NetImpairLicense
0 usd
CY2020 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
276060 shares
CY2020 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
13803 usd
CY2021Q1 elite Stock Issued During Period Share Issued For Services
StockIssuedDuringPeriodShareIssuedForServices
3042000 shares
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
152100 usd
CY2018Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
400000 shares
CY2018Q4 elite Note Original Debt Discount Amount
NoteOriginalDebtDiscountAmount
25500 usd
CY2018Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
400000 shares
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
45500 usd
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
40250 usd
CY2020Q1 elite Debt Discount
DebtDiscount
0 usd
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
22261 usd

Files In Submission

Name View Source Status
elite-20210331_cal.xml Edgar Link unprocessable
0001477932-23-006651-index-headers.html Edgar Link pending
0001477932-23-006651-index.html Edgar Link pending
0001477932-23-006651.txt Edgar Link pending
0001477932-23-006651-xbrl.zip Edgar Link pending
elite-20210331.xsd Edgar Link pending
elite_10q.htm Edgar Link pending
elite_10qimg5.jpg Edgar Link pending
elite_10qimg6.jpg Edgar Link pending
elite_ex311.htm Edgar Link pending
elite_ex312.htm Edgar Link pending
elite_ex321.htm Edgar Link pending
elite_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
elite-20210331_def.xml Edgar Link unprocessable
elite-20210331_lab.xml Edgar Link unprocessable
elite-20210331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elite_10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending